Liu David R. 4
4 · Prime Medicine, Inc. · Filed Oct 26, 2022
Insider Transaction Report
Form 4
Liu David R.
10% Owner
Transactions
- Conversion
Common Stock
2022-10-24+321,665→ 21,156,945 total - Conversion
Series A Convertible Preferred Stock
2022-10-24−1,000,001→ 0 total→ Common Stock (321,665 underlying)
Footnotes (1)
- [F1]The shares of Series A Convertible Preferred Stock (the "Series A Preferred Stock") were convertible into Common Stock on a one-for-3.10880 basis at any time at the option of the holder, and automatically converted into the number of shares shown in Column 7 immediately prior to the closing of the Issuer's initial public offering on October 24, 2022. The Series A Preferred Stock had no expiration date.